Tumor Mutational Burden Predicting the Efficacy of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review and Meta-Analysis

ObjectivesFor colorectal cancer patients, traditional biomarker deficient mismatch repair/microsatellite instability (dMMR/MSI) is an accurate predictor of immune checkpoint inhibitors (ICIs). Recent years, researchers considered tumor mutation burden (TMB) as another predictive biomarker which mean...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yan Li, Yiqi Ma, Zijun Wu, Fanxin Zeng, Bin Song, Yanrong Zhang, Jinxing Li, Su Lui, Min Wu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2021-09-01
Col·lecció:	Frontiers in Immunology
Matèries:	tumor mutation burden immune checkpoint inhibitors overall survival objective response rate colorectal cancer
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.751407/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!